Overview

Evaluating the Efficacy of Atomoxetine in Reducing Primary Nocturnal Enuresis in Children With ADHD: A Randomized, Placebo-Controlled Study

Status:
NOT_YET_RECRUITING

Trial end date:
2025-09-05

Target enrollment:

Participant gender:

Summary

1. Primary Aim: To evaluate the efficacy of atomoxetine in reducing the frequency of primary nocturnal enuresis episodes in children with ADHD. 2. Secondary Aim: To determine if improvements in attention symptoms correlate with reductions in nocturnal enuresis episodes.

Phase:

EARLY_PHASE1

Details

Lead Sponsor:

Tanta University

Treatments:

Atomoxetine Hydrochloride